EGFR and cancer: In certain cases, cancer cells may constitutively express PD-L1 as a result of the oncogenic activation of signaling pathways, such as those regulated by rat sarcoma (RAS), epidermal growth factor receptor (EGFR), and mitogen-activated protein kinases (MAPK), among others [57,64,65,66,67,68,69].